Tag Archives: Pharma

Rate Rumors and Reid’s Health Care Failure

Today’s podcast focuses on the rumors circulating about the Federal Reserve’s plans for an interest rate hike, and an update on where things stand on health care reform on Capitol Hill in the wake of a failed vote on doctor’s payments.

Drugs, Importation, and the Internet: A New Study

There is a danger from the internet but it can be contained, and it is only very rarely found in drugs imported from Europe. What this means, as the drugs industry knows, is that it will eventually lose the safety debate, and probably the entire importation debate with it.

How Medical Breakthroughs Happen: A Response to Megan McArdle

Megan McArdle bases a portion of her argument against nationalized health care on a surprisingly inaccurate depiction of the way medical research happens, one that needs rebutting if we’re going to keep the debate about reform of both the industry and the insurance side of health care based on facts about how the current system works, not polemics.

Prescription Drug Reimportation and the Economic Downturn

If the Obama administration allows large scale drug reimportation from Europe, EU nations will effectively set many drug prices in US. Rather than make the right but politically weak economic argument in response, industry is relying on a more shaky argument to deter reimportation — that imports from overseas are dangerous for the public’s health.

- March 21, 2010 -

MORE LEDGER

ELSEWHERE ON TNL

DAILY READS

MARKETS & POLICY

The WHIP

HEGEMON

CHEQUER BOARD